Charlotte Harrison
Senior Clinical Research Associate
Data updated
Research Footprint
Charlotte Harrison appears in 4 tracked papers (2021–2024), most studied alongside MDMA and Placebo, across PTSD, Safety & Risk Management and Depressive Disorders.
Most-cited paper: MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study (942 citations).
Frequent co-authors: Berra Yazar-Klosinski, Michael Mithoefer and Rick Doblin.
Background & Research
Charlotte Harrison is a Senior Clinical Research Associate at MAPS Public Benefit Corporation, where she has helped support clinical trial operations for MDMA-assisted psychotherapy research. A MAPS profile from 2017 describes her as contributing to the organization’s Phase 3 PTSD studies and having prior experience monitoring multiple clinical trials across therapeutic areas. She is associated with the MDMA-assisted therapy publications you listed, which suggests she has been involved in the research infrastructure supporting these late-stage trials.
Key Impact
She appears as an author on multiple MAPS phase 3 MDMA-assisted therapy papers, indicating a key operational role in the clinical trial program.
Collaboration Network
16 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Charlotte Harrison's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.
Affiliations
Institutions, companies, and organisations Charlotte Harrison is associated with.